ID   TDT_HUMAN               Reviewed;         509 AA.
AC   P04053; Q53FH1; Q5W103; Q96E50;
DT   01-NOV-1986, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   28-JUN-2023, entry version 219.
DE   RecName: Full=DNA nucleotidylexotransferase;
DE            EC=2.7.7.31 {ECO:0000269|PubMed:11473582, ECO:0000269|PubMed:16371131, ECO:0000269|PubMed:8163485};
DE   AltName: Full=Terminal addition enzyme;
DE   AltName: Full=Terminal deoxynucleotidyltransferase;
DE            Short=Terminal transferase {ECO:0000303|PubMed:11473582};
GN   Name=DNTT; Synonyms=TDT {ECO:0000303|PubMed:11473582};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT GLY-112.
RX   PubMed=2863268; DOI=10.1016/s0021-9258(19)85111-6;
RA   Peterson R.C., Cheung L.C., Mattaliano R.J., White S.T., Chang L.M.S.,
RA   Bollum F.J.;
RT   "Expression of human terminal deoxynucleotidyl transferase in Escherichia
RT   coli.";
RL   J. Biol. Chem. 260:10495-10502(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-112.
RX   PubMed=2833741; DOI=10.1073/pnas.85.8.2489;
RA   Riley L.K., Morrow J.K., Danton M.J., Coleman M.S.;
RT   "Human terminal deoxyribonucleotidyltransferase: molecular cloning and
RT   structural analysis of the gene and 5' flanking region.";
RL   Proc. Natl. Acad. Sci. U.S.A. 85:2489-2493(1988).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT GLY-112.
RX   PubMed=11554927; DOI=10.1046/j.1365-2443.2001.00460.x;
RA   Ibe S., Fujita K., Toyomoto T., Shimazaki N., Kaneko R., Tanabe A.,
RA   Takebe I., Kuroda S., Kobayashi T., Toji S., Tamai K., Yamamoto H.,
RA   Koiwai O.;
RT   "Terminal deoxynucleotidyltransferase is negatively regulated by direct
RT   interaction with proliferating cell nuclear antigen.";
RL   Genes Cells 6:815-824(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-112.
RC   TISSUE=Thymus;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLY-112.
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-67.
RX   PubMed=3395350; DOI=10.1016/0006-291x(88)90654-7;
RA   Koiwai O., Morita A.;
RT   "Isolation of putative promoter region for human terminal
RT   deoxynucleotidyltransferase gene.";
RL   Biochem. Biophys. Res. Commun. 154:91-100(1988).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 271-508 (ISOFORM 2).
RX   PubMed=6087320; DOI=10.1073/pnas.81.14.4363;
RA   Peterson R.C., Cheung L.C., Mattaliano R.J., Chang L.M.S., Bollum F.J.;
RT   "Molecular cloning of human terminal deoxynucleotidyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 81:4363-4367(1984).
RN   [9]
RP   MUTAGENESIS OF ASP-343, AND CATALYTIC ACTIVITY.
RX   PubMed=8163485; DOI=10.1016/s0021-9258(17)32652-2;
RA   Yang B., Gathy K.N., Coleman M.S.;
RT   "Mutational analysis of residues in the nucleotide binding domain of human
RT   terminal deoxynucleotidyl transferase.";
RL   J. Biol. Chem. 269:11859-11868(1994).
RN   [10]
RP   INTERACTION WITH DNTTIP1, CATALYTIC ACTIVITY, AND COFACTOR.
RC   TISSUE=Thymus;
RX   PubMed=11473582; DOI=10.1046/j.1365-2443.2001.00449.x;
RA   Yamashita N., Shimazaki N., Ibe S., Kaneko R., Tanabe A., Toyomoto T.,
RA   Fujita K., Hasegawa T., Toji S., Tamai K., Yamamoto H., Koiwai O.;
RT   "Terminal deoxynucleotidyltransferase directly interacts with a novel
RT   nuclear protein that is homologous to p65.";
RL   Genes Cells 6:641-652(2001).
RN   [11]
RP   INTERACTION WITH DNTTIP2 AND CORE HISTONE.
RX   PubMed=12786946; DOI=10.1046/j.1365-2443.2003.00656.x;
RA   Fujita K., Shimazaki N., Ohta Y., Kubota T., Ibe S., Toji S., Tamai K.,
RA   Fujisaki S., Hayano T., Koiwai O.;
RT   "Terminal deoxynucleotidyltransferase forms a ternary complex with a novel
RT   chromatin remodeling protein with 82 kDa and core histone.";
RL   Genes Cells 8:559-571(2003).
RN   [12]
RP   INTERACTION WITH PRP19.
RX   PubMed=12960389; DOI=10.1073/pnas.1631060100;
RA   Mahajan K.N., Mitchell B.S.;
RT   "Role of human Pso4 in mammalian DNA repair and association with terminal
RT   deoxynucleotidyl transferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:10746-10751(2003).
RN   [13]
RP   INTERACTION WITH DNTTIP1 AND TRERF1, SUBCELLULAR LOCATION, AND CATALYTIC
RP   ACTIVITY.
RX   PubMed=16371131; DOI=10.1111/j.1365-2443.2005.00916.x;
RA   Fujisaki S., Sato A., Toyomoto T., Hayano T., Sugai M., Kubota T.,
RA   Koiwai O.;
RT   "Direct binding of TReP-132 with TdT results in reduction of TdT
RT   activity.";
RL   Genes Cells 11:47-57(2006).
RN   [14]
RP   STRUCTURE BY NMR OF 19-125.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of BRCT domain of terminal
RT   deoxynucleotidyltransferase.";
RL   Submitted (NOV-2005) to the PDB data bank.
CC   -!- FUNCTION: Template-independent DNA polymerase which catalyzes the
CC       random addition of deoxynucleoside 5'-triphosphate to the 3'-end of a
CC       DNA initiator. One of the in vivo functions of this enzyme is the
CC       addition of nucleotides at the junction (N region) of rearranged Ig
CC       heavy chain and T-cell receptor gene segments during the maturation of
CC       B- and T-cells. {ECO:0000250|UniProtKB:P09838}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2'-deoxyribonucleoside 5'-triphosphate + DNA(n) =
CC         diphosphate + DNA(n+1); Xref=Rhea:RHEA:22508, Rhea:RHEA-COMP:17339,
CC         Rhea:RHEA-COMP:17340, ChEBI:CHEBI:33019, ChEBI:CHEBI:61560,
CC         ChEBI:CHEBI:173112; EC=2.7.7.31;
CC         Evidence={ECO:0000269|PubMed:11473582, ECO:0000269|PubMed:16371131,
CC         ECO:0000269|PubMed:8163485};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000305|PubMed:11473582};
CC       Note=Can also utilize other divalent cations, such as Mn(2+) and Co(2+)
CC       (in vitro). {ECO:0000250|UniProtKB:P09838, ECO:0000305};
CC   -!- SUBUNIT: Interacts with PRP19 and DNTTIP1. Forms a ternary complex with
CC       DNTTIP2 and core histone. Released from this complex by PCNA. Interacts
CC       with TRERF1 (PubMed:16371131). {ECO:0000269|PubMed:11473582,
CC       ECO:0000269|PubMed:12786946, ECO:0000269|PubMed:12960389,
CC       ECO:0000269|PubMed:16371131}.
CC   -!- INTERACTION:
CC       P04053; A8MW99: MEI4; NbExp=3; IntAct=EBI-1220259, EBI-19944212;
CC       P04053; Q04864: REL; NbExp=3; IntAct=EBI-1220259, EBI-307352;
CC       P04053; P15884-3: TCF4; NbExp=3; IntAct=EBI-1220259, EBI-13636688;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:16371131}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P04053-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P04053-2; Sequence=VSP_038397;
CC   -!- SIMILARITY: Belongs to the DNA polymerase type-X family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M11722; AAA36726.1; -; mRNA.
DR   EMBL; M20703; AAA53100.1; -; mRNA.
DR   EMBL; M22968; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20694; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20695; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20696; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20697; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20698; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20699; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20700; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20701; AAA53100.1; JOINED; mRNA.
DR   EMBL; M20702; AAA53100.1; JOINED; mRNA.
DR   EMBL; AB046378; BAB72001.1; -; mRNA.
DR   EMBL; AK223317; BAD97037.1; -; mRNA.
DR   EMBL; AL136181; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC012920; AAH12920.1; -; mRNA.
DR   EMBL; M21195; AAA61137.1; -; Genomic_DNA.
DR   EMBL; K01919; AAA61136.1; -; mRNA.
DR   CCDS; CCDS44465.1; -. [P04053-2]
DR   CCDS; CCDS7447.1; -. [P04053-1]
DR   PIR; A23924; WXHU.
DR   RefSeq; NP_001017520.1; NM_001017520.1. [P04053-2]
DR   RefSeq; NP_004079.3; NM_004088.3. [P04053-1]
DR   PDB; 2COE; NMR; -; A=19-125.
DR   PDB; 5W4E; X-ray; 2.18 A; A/D=7-22.
DR   PDBsum; 2COE; -.
DR   PDBsum; 5W4E; -.
DR   AlphaFoldDB; P04053; -.
DR   SMR; P04053; -.
DR   BioGRID; 108127; 13.
DR   CORUM; P04053; -.
DR   IntAct; P04053; 6.
DR   STRING; 9606.ENSP00000360216; -.
DR   BindingDB; P04053; -.
DR   ChEMBL; CHEMBL4810; -.
DR   DrugBank; DB02189; 2',3'-Dideoxyadenosine triphosphate.
DR   GlyGen; P04053; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P04053; -.
DR   PhosphoSitePlus; P04053; -.
DR   BioMuta; DNTT; -.
DR   DMDM; 311033533; -.
DR   jPOST; P04053; -.
DR   MassIVE; P04053; -.
DR   MaxQB; P04053; -.
DR   PaxDb; P04053; -.
DR   PeptideAtlas; P04053; -.
DR   ProteomicsDB; 51639; -. [P04053-1]
DR   ProteomicsDB; 51640; -. [P04053-2]
DR   Antibodypedia; 16924; 661 antibodies from 40 providers.
DR   DNASU; 1791; -.
DR   Ensembl; ENST00000371174.5; ENSP00000360216.2; ENSG00000107447.8. [P04053-1]
DR   Ensembl; ENST00000630152.1; ENSP00000486733.1; ENSG00000107447.8. [P04053-2]
DR   GeneID; 1791; -.
DR   KEGG; hsa:1791; -.
DR   MANE-Select; ENST00000371174.5; ENSP00000360216.2; NM_004088.4; NP_004079.3.
DR   UCSC; uc001kmf.4; human. [P04053-1]
DR   AGR; HGNC:2983; -.
DR   CTD; 1791; -.
DR   DisGeNET; 1791; -.
DR   GeneCards; DNTT; -.
DR   HGNC; HGNC:2983; DNTT.
DR   HPA; ENSG00000107447; Tissue enriched (lymphoid).
DR   MIM; 187410; gene.
DR   neXtProt; NX_P04053; -.
DR   OpenTargets; ENSG00000107447; -.
DR   PharmGKB; PA27449; -.
DR   VEuPathDB; HostDB:ENSG00000107447; -.
DR   eggNOG; KOG2534; Eukaryota.
DR   GeneTree; ENSGT00940000158584; -.
DR   HOGENOM; CLU_008698_0_0_1; -.
DR   InParanoid; P04053; -.
DR   OMA; PKVINLW; -.
DR   OrthoDB; 3019669at2759; -.
DR   PhylomeDB; P04053; -.
DR   TreeFam; TF103012; -.
DR   BRENDA; 2.7.7.31; 2681.
DR   PathwayCommons; P04053; -.
DR   SABIO-RK; P04053; -.
DR   SignaLink; P04053; -.
DR   BioGRID-ORCS; 1791; 14 hits in 1149 CRISPR screens.
DR   ChiTaRS; DNTT; human.
DR   EvolutionaryTrace; P04053; -.
DR   GeneWiki; Terminal_deoxynucleotidyl_transferase; -.
DR   GenomeRNAi; 1791; -.
DR   Pharos; P04053; Tchem.
DR   PRO; PR:P04053; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P04053; protein.
DR   Bgee; ENSG00000107447; Expressed in thymus and 28 other tissues.
DR   Genevisible; P04053; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003912; F:DNA nucleotidylexotransferase activity; IDA:UniProtKB.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006259; P:DNA metabolic process; IDA:UniProtKB.
DR   GO; GO:0006304; P:DNA modification; IEA:UniProtKB-KW.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; IBA:GO_Central.
DR   CDD; cd18443; BRCT_DNTT; 1.
DR   CDD; cd00141; NT_POLXc; 1.
DR   Gene3D; 1.10.150.20; 5' to 3' exonuclease, C-terminal subdomain; 1.
DR   Gene3D; 3.30.460.10; Beta Polymerase, domain 2; 1.
DR   Gene3D; 3.40.50.10190; BRCT domain; 1.
DR   Gene3D; 1.10.150.110; DNA polymerase beta, N-terminal domain-like; 1.
DR   Gene3D; 3.30.210.10; DNA polymerase, thumb domain; 1.
DR   InterPro; IPR001357; BRCT_dom.
DR   InterPro; IPR036420; BRCT_dom_sf.
DR   InterPro; IPR002054; DNA-dir_DNA_pol_X.
DR   InterPro; IPR019843; DNA_pol-X_BS.
DR   InterPro; IPR010996; DNA_pol_b-like_N.
DR   InterPro; IPR028207; DNA_pol_B_palm_palm.
DR   InterPro; IPR018944; DNA_pol_lambd_fingers_domain.
DR   InterPro; IPR027421; DNA_pol_lamdba_lyase_dom_sf.
DR   InterPro; IPR037160; DNA_Pol_thumb_sf.
DR   InterPro; IPR022312; DNA_pol_X.
DR   InterPro; IPR043519; NT_sf.
DR   InterPro; IPR029398; PolB_thumb.
DR   InterPro; IPR027292; TdT.
DR   InterPro; IPR001726; TdT/Mu.
DR   PANTHER; PTHR11276:SF21; DNA NUCLEOTIDYLEXOTRANSFERASE; 1.
DR   PANTHER; PTHR11276; DNA POLYMERASE TYPE-X FAMILY MEMBER; 1.
DR   Pfam; PF00533; BRCT; 1.
DR   Pfam; PF14792; DNA_pol_B_palm; 1.
DR   Pfam; PF14791; DNA_pol_B_thumb; 1.
DR   Pfam; PF10391; DNA_pol_lambd_f; 1.
DR   Pfam; PF14716; HHH_8; 1.
DR   PIRSF; PIRSF000817; DNA_NT; 1.
DR   PIRSF; PIRSF501175; TDT; 1.
DR   PRINTS; PR00869; DNAPOLX.
DR   PRINTS; PR00871; DNAPOLXTDT.
DR   SMART; SM00292; BRCT; 1.
DR   SMART; SM00483; POLXc; 1.
DR   SUPFAM; SSF52113; BRCT domain; 1.
DR   SUPFAM; SSF47802; DNA polymerase beta, N-terminal domain-like; 1.
DR   SUPFAM; SSF81301; Nucleotidyltransferase; 1.
DR   SUPFAM; SSF81585; PsbU/PolX domain-like; 1.
DR   PROSITE; PS50172; BRCT; 1.
DR   PROSITE; PS00522; DNA_POLYMERASE_X; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Magnesium; Metal-binding;
KW   Nucleotidyltransferase; Nucleus; Phosphoprotein; Reference proteome;
KW   Terminal addition; Transferase.
FT   CHAIN           1..509
FT                   /note="DNA nucleotidylexotransferase"
FT                   /id="PRO_0000218791"
FT   DOMAIN          27..124
FT                   /note="BRCT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00033"
FT   REGION          1..24
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          151..509
FT                   /note="Mediates interaction with DNTTIP2"
FT                   /evidence="ECO:0000269|PubMed:12786946"
FT   REGION          258..262
FT                   /note="Involved in DNA binding"
FT                   /evidence="ECO:0000250|UniProtKB:P09838"
FT   MOTIF           11..17
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:P06526"
FT   BINDING         333..338
FT                   /ligand="a 2'-deoxyribonucleoside 5'-triphosphate"
FT                   /ligand_id="ChEBI:CHEBI:61560"
FT                   /evidence="ECO:0000250|UniProtKB:P09838"
FT   BINDING         342..345
FT                   /ligand="a 2'-deoxyribonucleoside 5'-triphosphate"
FT                   /ligand_id="ChEBI:CHEBI:61560"
FT                   /evidence="ECO:0000250|UniProtKB:P09838"
FT   BINDING         343
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P09838"
FT   BINDING         345
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P09838"
FT   BINDING         433
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250|UniProtKB:P09838"
FT   BINDING         448..449
FT                   /ligand="a 2'-deoxyribonucleoside 5'-triphosphate"
FT                   /ligand_id="ChEBI:CHEBI:61560"
FT                   /evidence="ECO:0000250|UniProtKB:P09838"
FT   MOD_RES         134
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P09838"
FT   VAR_SEQ         454
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:2863268,
FT                   ECO:0000303|PubMed:6087320"
FT                   /id="VSP_038397"
FT   VARIANT         112
FT                   /note="R -> G (in dbSNP:rs6584066)"
FT                   /evidence="ECO:0000269|PubMed:11554927,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:2833741,
FT                   ECO:0000269|PubMed:2863268, ECO:0000269|Ref.4"
FT                   /id="VAR_058200"
FT   MUTAGEN         343
FT                   /note="D->E: Nearly abolishes enzyme activity."
FT                   /evidence="ECO:0000269|PubMed:8163485"
FT   CONFLICT        51
FT                   /note="F -> L (in Ref. 4; BAD97037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        299
FT                   /note="L -> P (in Ref. 4; BAD97037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        329
FT                   /note="T -> A (in Ref. 4; BAD97037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        383
FT                   /note="T -> A (in Ref. 4; BAD97037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        389
FT                   /note="L -> M (in Ref. 4; BAD97037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        452
FT                   /note="S -> SP (in Ref. 2; AAA53100)"
FT                   /evidence="ECO:0000305"
FT   STRAND          23..25
FT                   /evidence="ECO:0007829|PDB:2COE"
FT   STRAND          36..40
FT                   /evidence="ECO:0007829|PDB:2COE"
FT   TURN            42..44
FT                   /evidence="ECO:0007829|PDB:2COE"
FT   HELIX           46..58
FT                   /evidence="ECO:0007829|PDB:2COE"
FT   STRAND          73..78
FT                   /evidence="ECO:0007829|PDB:2COE"
FT   HELIX           81..90
FT                   /evidence="ECO:0007829|PDB:2COE"
FT   STRAND          100..103
FT                   /evidence="ECO:0007829|PDB:2COE"
FT   HELIX           104..112
FT                   /evidence="ECO:0007829|PDB:2COE"
FT   STRAND          120..124
FT                   /evidence="ECO:0007829|PDB:2COE"
SQ   SEQUENCE   509 AA;  58536 MW;  0EC01E380FA7E5A2 CRC64;
     MDPPRASHLS PRKKRPRQTG ALMASSPQDI KFQDLVVFIL EKKMGTTRRA FLMELARRKG
     FRVENELSDS VTHIVAENNS GSDVLEWLQA QKVQVSSQPE LLDVSWLIEC IRAGKPVEMT
     GKHQLVVRRD YSDSTNPGPP KTPPIAVQKI SQYACQRRTT LNNCNQIFTD AFDILAENCE
     FRENEDSCVT FMRAASVLKS LPFTIISMKD TEGIPCLGSK VKGIIEEIIE DGESSEVKAV
     LNDERYQSFK LFTSVFGVGL KTSEKWFRMG FRTLSKVRSD KSLKFTRMQK AGFLYYEDLV
     SCVTRAEAEA VSVLVKEAVW AFLPDAFVTM TGGFRRGKKM GHDVDFLITS PGSTEDEEQL
     LQKVMNLWEK KGLLLYYDLV ESTFEKLRLP SRKVDALDHF QKCFLIFKLP RQRVDSDQSS
     WQEGKTWKAI RVDLVLCPYE RRAFALLGWT GSRQFERDLR RYATHERKMI LDNHALYDKT
     KRIFLKAESE EEIFAHLGLD YIEPWERNA
//
